House Ways and Means/Health Subcommittee
James Reuter will join staff in April, replacing Stephen Bandeian, who is moving to Office of Management and Budget. A five-year veteran of the Congressional Research Service, Reuter specialized in research and analysis of Medicare Part B issues.
You may also be interested in...
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
US FDA Commissioner Race Shrinks And Widens: Biden Team Trying To Woo Reluctant Dems On Woodcock While Exploring New Options
White House is trying to overcome some Senate Democrats’ opposition to Janet Woodcock as FDA Commissioner, while also looking for other candidates for the job. Josh Sharfstein, long thought to be Woodcock’s main competition, is not a strong contender.